Hong Kong stocks are fluctuating | Innovative drug concept rises against the market trend, National Medical Insurance negotiations for 2025 start, many pharmaceutical companies show outstanding third-quarter performance.

According to the Wise Finance APP, the concept of innovative drugs went up against the market today. As of the time of publication, Sino Biopharmaceutical (01530.HK) rose by 11.42% to 30.84 Hong Kong dollars; Sino Biopharmaceutical (01801.HK) rose by 8.12% to 87.25 Hong Kong dollars; Hengrui Pharma-B (06990.HK) rose by 6.97% to 451 Hong Kong dollars; CanSino Biologics-B (02162) rose by 4.71% to 60.05 Hong Kong dollars; Hansoh Pharma (03692) rose by 4.56% to 35.76 Hong Kong dollars.